24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Genomics, technology, bioinformatics<br />

P08.77<br />

Genomic regulation <strong>of</strong> gene-expression levels in the brain<br />

during human evolution<br />

M. Cáceres 1,2 , L. Armengol 1 , J. W. Thomas 2 , T. M. Preuss 3 , X. Estivill 1 ;<br />

1 Genes and Disease Program, Center for Genomic Regulation (CRG-UPF) and<br />

CIBERESP, <strong>Barcelona</strong>, Spain, 2 Department <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, Emory University<br />

School <strong>of</strong> Medicine, Atlanta, GA, United States, 3 Division <strong>of</strong> Neuroscience<br />

and Center for Behavioral Neuroscience, Yerkes National Primate Research<br />

Center, Atlanta, GA, United States.<br />

For the last few years, several groups have used microarrays to compare<br />

transcript levels in humans and non-human primates and have<br />

identified hundreds <strong>of</strong> candidate genes with expression changes in the<br />

human brain . Here, a multidisciplinary approach, including experimental<br />

techniques and bioinformatic analysis <strong>of</strong> genome sequence and<br />

gene-expression data, is proposed to obtain a more pr<strong>of</strong>ound understanding<br />

<strong>of</strong> the potential causes and effects <strong>of</strong> these gene expression<br />

changes . Preliminary sequence comparisons have yielded examples<br />

<strong>of</strong> diverse types <strong>of</strong> mechanisms that could account for the observed<br />

differences in mRNA levels, such as multiple gene duplications, insertion<br />

<strong>of</strong> transposable elements in 3’ UTR or upstream regions, and a<br />

single nucleotide mutation in the polyA signal . In addition, as an example<br />

<strong>of</strong> the proposed strategy, a global analysis <strong>of</strong> the regulatory sequences<br />

<strong>of</strong> the thrombospondin 4 (THBS4) gene has been carried out .<br />

This gene is involved in synapse formation and shows a six-fold upregulation<br />

in humans that is specific <strong>of</strong> the forebrain. Interestingly, an<br />

excess <strong>of</strong> nucleotide changes and an Alu insertion were found in the<br />

THBS4 promoter region in the human lineage . However, in vitro gene<br />

reporter assays indicated that the human and chimpanzee promoter<br />

fragments have similar transcriptional activity, and computational prediction<br />

<strong>of</strong> transcription factor binding sites suggests that THBS4 upregulation<br />

could be due to changes in trans-acting regulators . Overall,<br />

these results provide insights into the regulatory mechanisms acting at<br />

various levels and the evolutionary role <strong>of</strong> gene-expression regulation,<br />

and could help us to determine the molecular basis <strong>of</strong> human-specific<br />

traits .<br />

P08.78<br />

Using genome-wide pathway analysis to unravel the etiology <strong>of</strong><br />

a complex disease like type 2 diabetes<br />

C. C. Elbers 1,2 , K. R. van Eijk 1 , L. Franke 1,3 , F. Mulder 1 , Y. T. van der Schouw 2 ,<br />

C. Wijmenga 1,3 , N. C. Onland-Moret 1,2 ;<br />

1 Complex <strong>Genetics</strong> Section, Dept. <strong>of</strong> Biomedical <strong>Genetics</strong>, University Medical<br />

Center Utrecht, Utrecht, The Netherlands, 2 Julius Center for Health Sciences<br />

and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands,<br />

3 Department <strong>of</strong> <strong>Genetics</strong>, University Medical Center Groningen and<br />

University <strong>of</strong> Groningen, Groningen, The Netherlands.<br />

Several genome-wide association studies (GWAS) have recently<br />

been published on a variety <strong>of</strong> complex diseases . However, 99 .9% <strong>of</strong><br />

GWAS data is currently discarded and not analyzed to its full potential<br />

. In this study, we took a different approach and aimed to evaluate<br />

alternative methods <strong>of</strong> obtaining valuable information on disease etiology<br />

from GWAS data . We assessed whether we could detect overrepresented<br />

biological pathways in the GWAS datasets, by combining<br />

a network-based tool, ‘Prioritizer’, with a pathway-classification tool,<br />

‘PANTHER’ .<br />

As an example, we used publicly available data from two type 2 diabetes<br />

(T2D) GWAS; the Diabetes <strong>Genetics</strong> Initiative (DGI) and the Wellcome<br />

Trust Case Control Consortium (WTCCC) . Of the 1,179 SNPs<br />

in the DGI dataset and the 1,712 SNPs in the WTCCC dataset that<br />

showed association with T2D with a p-value lower than 0 .003, we were<br />

able to map 559 and 797 SNPs, respectively, to genomic loci that contained<br />

one or more genes . Prioritizer then selected the most promising<br />

gene(s) from each locus based on their functional interactions with<br />

genes on the other loci . We used PANTHER to assign each <strong>of</strong> the<br />

selected genes to a specific pathway and to test whether we saw more<br />

genes in each pathway than expected .<br />

Our results showed that the ‘inflammation mediated by chemokine and<br />

cytokine signaling’ and ‘Wnt signaling’ pathways were consistently the<br />

most strongly overrepresented in the T2D data . By taking an alternative<br />

approach, we have shown it is possible to detect biological mechanisms<br />

in GWAS data .<br />

P08.79<br />

Ultra-High-throughput sequencing in heterogeneous<br />

inherited heart disorders: a first experience in Hypertrophic<br />

cardiomyopathy<br />

S. Fokstuen 1 , C. Iseli 2,3 , D. Robyr 4 , A. Munoz 4 , S. E. Antonarakis 4,1 , J. L. Blouin<br />

1 ;<br />

1 Genetic Medicine, University Hospitals <strong>of</strong> Geneva, Geneva, Switzerland, 2 Ludwig<br />

Institute for Cancer Research, Lausanne, Switzerland, 3 Swiss Institute <strong>of</strong><br />

Bioinformatics, Lausanne, Switzerland, 4 Genetic Medicine, University <strong>of</strong> Geneva<br />

School <strong>of</strong> Medicine, Geneva, Switzerland.<br />

During last decade, molecular genetics has provided new insights into<br />

the pathogenesis <strong>of</strong> inherited heart disorders and Hypertrophic Cardiomyopathy<br />

(HCM) represents the most common one (1/500) . Genetic<br />

testing has a growing impact on the management <strong>of</strong> patients and their<br />

families . However, the extensive genetic heterogeneity <strong>of</strong> these disorders<br />

requires the use <strong>of</strong> high-throughput mutation detection strategies<br />

for clinical screening . We had developed a 30-Kb HCM-Custom-DNAresequencing-array<br />

(HCM-RA) comprising all exons (n=160), splicesites<br />

and 5’-UTR <strong>of</strong> 12 HCM genes. Although very efficient in detecting<br />

single nucleotide variants, this approach did not identify small indels,<br />

accounting for 14% <strong>of</strong> HCM mutations . Moreover, resequencing-arrays<br />

lack flexibility since gene additions requires a new design.<br />

In order to overcome the shortcomings <strong>of</strong> microarray-resequencing<br />

we assessed the performance <strong>of</strong> the recently developed Ultra-High-<br />

Throughput-Sequencing (UHTS) . We reanalysed these 12 genes in<br />

a total <strong>of</strong> 19 patients, hybridized previously on HCM-RA (8 positivecontrols<br />

as a composite-pool and 11 DNA without mutation), in a single<br />

channel <strong>of</strong> a SOLEXA . Every single base <strong>of</strong> the sequence (570 fold<br />

coverage accounting for 24 alleles) was analyzed using a newly developed<br />

data analysis pipeline .<br />

All the 8 control mutations and 18 SNPs previously identified by<br />

HCM-RA were also observed in UHTS . Furthermore sequence alterations<br />

and particularly indels were detected such as c .1028delC/<br />

p .Thr343fsX349, [c .2146-9C>A+c .2146-2delA], c .506-12delC in gene<br />

MYBPC3, c .53-15_-11delTTCTC in TNNT2 . Although evolution and<br />

improvement in DNA target enrichment, specificity and data analysis<br />

are needed, UHTS holds considerable promises in mutation/variant<br />

analysis underlying highly heterogeneous or multigenic pathologic<br />

conditions in clinical practice as well .<br />

P08.80<br />

Advantages <strong>of</strong> universal primers use in biochip analysis <strong>of</strong><br />

trombosis genes polymorphism<br />

A. S. Glotov 1,2 , E. S. Vashukova 1,2 , L. B. Polushkina 1 , O. N. Mityaeva 3 , T. V.<br />

Nasedkina 3 , I. V. Goldenkova-Pavlova 4 , T. E. Ivaschenko 1 , M. S. Zainulina 1 , V.<br />

S. Baranov 1 ;<br />

1 Ott’s Institute <strong>of</strong> Obstetrics&Gynecology, St.-Petersburg, Russian Federation,<br />

2 Saint-Petersburg State University, Saint-Petersburg, Russian Federation, 3 Engelgardt<br />

Institute <strong>of</strong> Molecular Biology, Moscow, Russian Federation, 4 Vavilov<br />

Institute <strong>of</strong> General <strong>Genetics</strong>, Moscow, Russian Federation.<br />

Genetic testing <strong>of</strong> inherited predisposition to frequent multifactor diseases<br />

needs new screening methods <strong>of</strong> DNA-polymorphism analysis .<br />

The most advanced approaches in genetic testing <strong>of</strong> multifactorial<br />

diseases usually include multi-locus DNA amplification. The multiplex<br />

PCR method could be significantly improved by means <strong>of</strong> the universal<br />

sequences incorporated into locus-specific primers. We have selected<br />

such DNA sequences and used them for two-step PCR genotyping <strong>of</strong><br />

F2, MTHFR, F5, PAI1, GPIIIa, FGB polymorphism with the subsequent<br />

hybridization on oligonucleotide biochips . Use <strong>of</strong> this technique opens<br />

an ample opportunity for the fast and reliable detection <strong>of</strong> inherited<br />

thrombosis . The method could be easily adopted in any molecular diagnostic<br />

laboratory .<br />

The work was partly supported by BRHE Fellowship competition 2006<br />

(Y4-B-12-02), Saint-Petersburg Personal grant for PhD (PD 07-1 .4-<br />

129), and grant <strong>of</strong> Russian Foundation for Basic Research (N 07-04-<br />

12271-<strong>of</strong>i)<br />

e-mail: anglotov@mail.ru

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!